Price $18.33 |
Market Cap
736M
|
Sector Health Care |
Div. Growth
-100.00%
|
|
P/E
16.9
|
P/B
3.15
|
P/S
3.06
|
Dividend %
-
|
|
P/CF
90.2
|
P/FCF
20.5
|
Op. Cash Flow
39K
|
FCF
0.8
|
|
Op. Margin
24.00%
|
Net Margin
18.20%
|
ROE
21.20%
|
ROI
9.60%
|
|
ROA
12.50%
|
EPS Growth
69.00%
|
Current Ratio
6.9
|
Debt/Equity
39.70%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Teva Pharmaceutical Industries (TEVA) | $9.35 | - | - | 10.2B | Strong Buy |
| Cumberland Pharmaceuticals, In (CPIX) | $3.02 | - | - | 48.7M | Strong Buy |
| CytomX Therapeutics Inc (CTMX) | $6.76 | - | - | 319.2M | Strong Buy |
| Diversicare Healthcare Service (DVCR) | $3.20 | - | - | 12M | Strong Buy |
| Dynatronics Corporation (DYNT) | $0.68 | - | - | 9.7M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
